Study of low and intermediate risk Neuroblastoma
- Conditions
- INTERMEDIATE AND LOW RISK NEUROBLASTOMATherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2010-021396-81-NO
- Lead Sponsor
- INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 685
DIFFERENT FOR EACH OF THE 10 STUDY GROUPS, DEPENDING ON THE AGE OF THE PATIENT, THE INRG STAGE, BIOLOGICAL CHARACTERISTICS OF THE TUMOR AND THE PRESENCE OF LIFE THREATENING SYMPTOMS, PLEASE CONSULT PROTOCOL.
Are the trial subjects under 18? yes
Number of subjects for this age range: 685
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
OVERALL EXCLUSION CRITERIA: DIAGNOSIS OF GANGLIONEUROMA OR GANGLIONEUROBLASTOMA INTERMIXED.
THE REMAINDER OF THE EXCLUSION CRITERIA ARE DIFFERENT FOR EACH OF THE 10 STUDY GROUPS, DEPENDING ON THE AGE OF THE PATIENT, THE INRG STAGE, BIOLOGICAL CHARACTERISTICS OF THE TUMOR AND THE PRESENCE OF LIFE THREATENING SYMPTOMS, PLEASE CONSULT PROTOCOL.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method